Delivery Order SPE2DB20D3303-SPE2DB25FA2EH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,801.43 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Contrave is an FDA-approved prescription medication used for chronic weight...
- The Defense Logistics Agency awarded a delivery order valued at $15,878.61 to AmerisourceBergen Drug Corp for CONTRAVE ER 8-90 mg tablets (120-count) on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. CONTRAVE is a prescription weight-management medication combining naltrexone and bupropion,...
- The Defense Logistics Agency awarded a delivery order valued at $2,831.99 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count) on August 22, 2025, with completion scheduled for August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Contrave is a prescription medication used for weight management, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $1,352.44 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count) on September 11, 2025, with completion expected by September 12, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $8,623.35 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120-count units) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Contrave is an FDA-approved weight management medication...
- The Defense Logistics Agency awarded a delivery order valued at $1,061.90 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Contrave ER 8-90 mg tablets (120-unit quantity). This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,515.09 delivery order for Contrave ER 8-90 mg tablets (120-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $22,397.23 to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120 count) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units) valued at $2,449.83 with a completion date of August 1, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract will be performed at the vendor's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,456.46 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2EHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,227.78 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Contrave ER 8-90 mg tablets (120 count). This non-competitive delivery order is structured as a firm fixed-price contract with a completion deadline of August 6, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Contrave is a prescription weight-management medication combining naltrexone and bupropion, supporting the Department of Defense's medical supply requirements for military healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that authorizes the company to supply pharmaceutical products and medical commodities globally. As one of the nation's leading pharmaceutical distributors, AmerisourceBergen regularly fulfills federal medical procurement needs through competitively awarded contracts with DLA, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 8/5/25 |